Elevated plasma IL-8 predicts for reduced outcomes in CCTG MA.38, a phase 2 randomized trial of palbociclib in ER+/HER2-metastatic breast cancer patientsHyma V. Polimera,Dhirisha Bhatt,Lois E. Shepherd,Karen Gelmon,Anil A. Joy,Wendy R. Parulekar,Monika Joshi,Suhail M. Ali,Kim Leitzel,Cristina Truica,Monali Vasekar,Joseph J. Drabick,Harry Menon,Neal Shah, Ashok Maddukuri,Prashanth Moku,E. Scott Halstead,Daniel McKeone,Todd M. Umstead,B. E. Chen,Allan LiptonCANCER RESEARCH（2022）引用 0|浏览17暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
